Patricia C Priest1, Lance C Jennings1, Alasdair R Duncan1, Cheryl R Brunton1, Michael G Baker1. 1. Patricia C. Priest is with the Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand. Lance C. Jennings is with the Department of Pathology, University of Otago Christchurch and Canterbury Health Laboratories, Christchurch, New Zealand. Alasdair R. Duncan and Cheryl R. Brunton are with the Department of Public Health and General Practice, University of Otago Christchurch. Michael G. Baker is with the Department of Public Health, University of Otago Wellington, Wellington, New Zealand.
Abstract
OBJECTIVES: We measured symptom and influenza prevalence, and the effectiveness of symptom and temperature screening for identifying influenza, in arriving international airline travelers. METHODS: This cross-sectional study collected data from travelers to Christchurch International Airport, New Zealand, in winter 2008, via a health questionnaire, temperature testing, and respiratory sampling. RESULTS: Forms were returned by 15 976 (68%) travelers. Of these, 17% reported at least 1 influenza symptom, with runny or blocked nose (10%) and cough (8%) most common. Respiratory specimens were obtained from 3769 travelers. Estimated prevalence of influenza was 1.1% (4% among symptomatic, 0.2% among asymptomatic). The sensitivity of screening criteria ranged from 84% for "any symptom" to 3% for a fever of 37.8 °C or greater. The positive predictive value was low for all criteria. CONCLUSIONS: Border screening using self-reported symptoms and temperature testing has limitations for preventing pandemic influenza from entering a country. Using "any symptom" or cough would lead to many uninfected people being investigated, yet some infected people would remain undetected. If more specific criteria such as fever were used, most infected people would enter the country despite screening.
OBJECTIVES: We measured symptom and influenza prevalence, and the effectiveness of symptom and temperature screening for identifying influenza, in arriving international airline travelers. METHODS: This cross-sectional study collected data from travelers to Christchurch International Airport, New Zealand, in winter 2008, via a health questionnaire, temperature testing, and respiratory sampling. RESULTS: Forms were returned by 15 976 (68%) travelers. Of these, 17% reported at least 1 influenza symptom, with runny or blocked nose (10%) and cough (8%) most common. Respiratory specimens were obtained from 3769 travelers. Estimated prevalence of influenza was 1.1% (4% among symptomatic, 0.2% among asymptomatic). The sensitivity of screening criteria ranged from 84% for "any symptom" to 3% for a fever of 37.8 °C or greater. The positive predictive value was low for all criteria. CONCLUSIONS: Border screening using self-reported symptoms and temperature testing has limitations for preventing pandemic influenza from entering a country. Using "any symptom" or cough would lead to many uninfected people being investigated, yet some infected people would remain undetected. If more specific criteria such as fever were used, most infected people would enter the country despite screening.
Authors: Timothy M Uyeki; Ramakrishna Prasad; Charles Vukotich; Samuel Stebbins; Charles R Rinaldo; Yu-Hui Ferng; Stephen S Morse; Elaine L Larson; Allison E Aiello; Brian Davis; Arnold S Monto Journal: Clin Infect Dis Date: 2009-05-01 Impact factor: 9.079
Authors: Fabrice Carrat; Elisabeta Vergu; Neil M Ferguson; Magali Lemaitre; Simon Cauchemez; Steve Leach; Alain-Jacques Valleron Journal: Am J Epidemiol Date: 2008-01-29 Impact factor: 4.897
Authors: Neil M Ferguson; Derek A T Cummings; Christophe Fraser; James C Cajka; Philip C Cooley; Donald S Burke Journal: Nature Date: 2006-04-26 Impact factor: 49.962
Authors: David Bell; Angus Nicoll; Keiji Fukuda; Peter Horby; Arnold Monto; Frederick Hayden; Clare Wylks; Lance Sanders; Jonathan Van Tam Journal: Emerg Infect Dis Date: 2006-01 Impact factor: 6.883
Authors: Justin Lessler; Nicholas G Reich; Ron Brookmeyer; Trish M Perl; Kenrad E Nelson; Derek A T Cummings Journal: Lancet Infect Dis Date: 2009-05 Impact factor: 25.071